| N cases | Overall Breast cancer | N casesa | ER+/ PR+ | N casesa | ER+/ PR- | N casesa | ER-/PR- |
---|---|---|---|---|---|---|---|---|
Changes in PA levelb | Â | Â | Â | RR (95% CI)c | Â | RR (95% CI)c | Â | RR (95% CI)c |
Age 14 to age 30 | Â | Â | Â | Â | Â | Â | Â | Â |
Inactive | 75 | 0.78 (0.62, 0.99) | 37 | 0.79 (0.56, 1.10) | 9 | 0.53 (0.27, 1.03) | 10 | 0.91 (0.48, 1.73) |
Active to inactive | 163 | 1.18 (1.0, 1.39) | 96 | 1.43 (1.15, 1.78) | 27 | 1.10 (0.74, 1.65) | 11 | 0.72 (0.39, 1.32) |
Inactive to active | 125 | 0.81 (0.67,0 .97) | 56 | 0.74 (0.56, 0.97) | 20 | 0.73 (0.46, 1.15) | 21 | 1.16 (0.73. 1.82) |
Active | 1334 | 1.0 ref | 650 | 1.0 ref | 229 | 1.0 ref | 155 | 1.0 ref |
Age 14 to enrollment | Â | Â | Â | Â | Â | Â | Â | Â |
Inactive | 72 | 0.82 (0.64, 1.03) | 34 | 0.75 (0.53, 1.06) | 9 | 0.63 (0.32, 1.24) | 10 | 1.06 (0.56, 2.03) |
Active to inactive | 419 | 1.06 (0.95, 1.20) | 203 | 1.00 (0.85, 1.18) | 78 | 1.29 (0.98, 1.69) | 44 | 1.07 (0.75, 1.52) |
Inactive to active | 130 | 0.79 (.66, 0.95) | 59 | 0.71 (0.54, 0.93) | 20 | 0.71 (0.45, 1.13) | 21 | 1.12 (0.70, 1.77) |
Active | 1091 | 1.0 ref | 550 | 1.0 ref | 179 | 1.0 ref | 124 | 1.0 ref |
Age 30 to enrollment | Â | Â | Â | Â | Â | Â | Â | Â |
Inactive | 146 | 1.06 (0.89, 1.27) | 79 | 1.15 (0.91, 1.46) | 24 | 1.05 (0.69, 1.62) | 11 | 0.72 (0.39, 1.33) |
Active to inactive | 347 | 1.04 (0.92, 1.18) | 160 | 0.95 (0.79, 1.13) | 64 | 1.27 (0.95, 1.69) | 43 | 1.18 (0.83, 1.67) |
Inactive to active | 94 | 1.01 (0.82, 1.25) | 55 | 1.19 (0.90, 1.57) | 12 | 0.77 (0.43, 1.37) | 11 | 1.01 (0.54, 1.87) |
Active | 1136 | 1.0 ref | 562 | 1.0 ref | 188 | 1.0 ref | 136 | 1.0 ref |